Aesthetic Medical Devices

June 18, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2606E09] Huons Meditech is a total solutions company that provides medical equipment such as aesthetic medical devices, ESWL, disinfectants, and sterilizers.
Huons Meditech is preparing for further advances with a new strategy for sustainable growth. In the future, executives and employees of Huons Meditech will be developing innovative medical devices based on stable and satisfying workplaces and creative medical technologies.

Automatic Mesotherapy Injector
Huons Meditech’s Derma Shine Pro is an automatic mesotherapy injector using vacuum pressure.
The product’s automatic pressure-detection system effectively narrows the gap between the 9-pin multi-screw needles and the skin surface to ensure that the medication is safely and effectively injected into the treatment area, thereby directly improving skin condition.
The built-in auto-sensing vacuum technology enables more precise and uniform injection than the manual treatment.
The product enables fast and effective treatment by using multi-needle cartridges. Accordingly, it only takes five minutes to complete the full-face treatment with 80 shots.

Automated Endoscope Reprocessor
Huons Meditech’s HUEN Single is a single-use automated endoscope reprocessor. It uses a disposable peracetic acid solution, and it disinfects the lumen of ductile endoscopy. It inhibits biofilm production and kills all pathogenic microorganisms, including spores, within five minutes in order to prevent cross-infection between patients.
It also significantly improves user convenience with powerful ultrasonic-cleaning functions and various options (automatic doors, air guns, chamber trays, bar code systems, etc.).

“Through our steady research and development, we aim to be the best global medical-device company that manufactures and supplies medical devices to various treatment fields necessary for the healthy life of humankind,” explained the company’s CEO, adding, “We are committed to providing the best medical devices that are safer and more effective, so that customers around the globe can lead a happier life through appreciating the real value of beauty and health.”
 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With: , ,

Ophthalmic Diagnostic Equipment

June 18, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2606E08] UMI Optics is a venture specializing in the field of ophthalmology. Its main products include ophthalmic diagnostic equipment such as fundus cameras and slit lamps with digital interface optical modules, which it developed using its own technology. These products are not only exported to international markets but also sold domestically.
After establishing a cleanroom (Class 10,000), UMI Optics began producing punctual plugs for dry-eye relief and Schirmer strips for measuring tear secretion, thus expanding its business into the ophthalmic consumables market.

Since 2018, UMI Optics has been conducting national R&D projects and successfully developed a non-mydriatic fundus camera, and it is actively working to expand both domestic and international sales channels.
The fundus camera is a device used to observe the state and lesions of the fundus. It is utilized not only to assess fundus findings but also in screenings for adult diseases such as hypertension and diabetes. It is thus used in primary healthcare institutions such as ophthalmology, internal medicine, and family medicine. With the global increase in the prevalence of adult diseases, there is growing awareness of the importance of early screening for the major complications of these diseases, including the three leading causes of blindness: macular degeneration, diabetic retinopathy, and glaucoma.
UMI Optics’ fundus camera (Model name: RETVIEW100) features an automatic imaging function that allows medical staff, even without specialized ophthalmology training, to easily capture fundus images. In addition, it is a non-mydriatic fundus camera, meaning that no dilation agent is required, allowing the fundus examination to be completed quickly.
A key feature of this camera is its integration with an AI solution that detects the presence of lesions associated with the three major causes of blindness: diabetic retinopathy, macular degeneration, and glaucoma.

This enables primary healthcare institutions such as internal medicine, family medicine, public health centers, and screening centers to conduct preliminary screenings for these diseases without the need for collaboration with ophthalmologists.
This improves access to early detection in primary-care settings, where healthcare access is higher than in ophthalmology departments. By preventing delays in treatment through early screening for the major causes of blindness, it is also expected to reduce national healthcare costs related to blindness.
 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:

Laser-based Aesthetic Medical Devices

June 18, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2606E07] ELEMENIC is a specialized manufacturer of laser-based aesthetic medical devices. By advancing the technology of traditional single- or dual-wavelength long-pulse lasers, ELEMENIC introduced the ELEMENT-TL, a triple-wavelength, long-pulse laser that has significantly enhanced the technological standards of Korea’s medical laser industry.
Additionally, with innovations such as the ELEMENT-PICO picosecond laser, ELEMENIC has gained positive recognition in the market.
ELEMENIC’s ELEMENT-TL is a long-pulse laser offering three simultaneous wavelengths — 532nm, 755nm, and 1064nm. It is a multifunctional laser system for advanced aesthetic dermatology treatments, certified by both the U.S. FDA and the EU’s CE Marking. With its ability to perform treatments across three laser wavelength ranges using a single device, the ELEMENT-TL delivers exceptional efficiency and cost-effectiveness.

ELEMENIC’s ELEMENT-PICO is a dual-pulse pico laser that operates in both picosecond and nanosecond modes. Featuring a true 450 picoseconds pulse duration and 1.8 GW peak power, it is designed to provide optimal results for professional dermatological applications, making it a highly effective solution for aesthetic treatments.
The company’s CEO noted, “We are a company dedicated to the research, development, and manufacturing of advanced medical laser systems. With innovative optical engineering and precise energy-control technologies, we deliver safe and effective medical solutions for modern clinical environments. Through continuous research and technological innovation, we develop highly reliable devices that provide both safety and treatment efficiency in dermatology and aesthetic medicines.”
Driven by globally recognized quality standards and strong technological expertise, ELEMENIC continues to expand its presence in the global medical device market. It is committed to advancing medical laser technology and contributing to safer and more precise treatment solutions worldwide.


 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story

Wearable EEG Sleep-Disorder Monitoring System

June 18, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2606E06] Slowave Inc. is a digital neuro-healthcare company that supports clinical decision-making through patch-type wearable EEG (electroencephalogram) sensor technology and advanced signal-analysis algorithms.
Slowave has independently developed lightweight, wireless wearable EEG devices and precision signal-processing technology, and continues to conduct research and development aimed at acquiring quantitative brain-signal data applicable to various neuropsychiatric conditions, including sleep disorders, delirium, and ADHD.
Slowave is further advancing its brain signal analysis capabilities into clinically applicable diagnostic support systems. In the future, the company plans to integrate neuromodulation technologies to link analysis and treatment, thereby expanding into precision neuro-medicine systems. Through this approach, Slowave aims to grow as a neurotech company contributing to the establishment of data-driven neurological disease management environments.

Slowave has completed international CB certification and GMP certification for its proprietary patch-type wearable EEG hardware, securing medical device–level technical reliability and manufacturing quality-management standards. Based on this foundation, the company has commercialized its lightweight, wireless brainwave monitoring system, Slowave 1.0, providing quantitative EEG data that clinicians can reference during patient consultations and expanding its potential for clinical application.
Slowave is also engaged in international research collaboration. It is conducting joint research on EEG-based delirium analysis in collaboration with the University of Michigan Medical School in the United States, and is expanding its clinical research network in the U.S. market. In addition, it plans to participate in the SLEEP 2026 conference and exhibition to validate its technology in North America and broaden global partnerships.

Slowave is a Class-II medical device certified by the Ministry of Food and Drug Safety (MFDS) in Korea. It is a wireless, wearable EEG-based sleep-monitoring system developed to complement the limitations of conventional hospital-based testing environments. By applying a patch-type electrode structure, it reduces the inconvenience of multi-channel electrode attachment and dependence on large diagnostic equipment.
Once prescribed, patients can conduct sleep measurements at home or in other convenient environments, and clinicians review the analyzed results during consultations. This model enhances the traditional single-session, hospital-based testing structure by enabling repeated and continuous brainwave monitoring.
Notably, Slowave utilizes its proprietary Phase Information Analysis (PIA) algorithm to perform precise EEG-signal analysis. The system aims to provide quantitative data applicable not only to sleep-disorder evaluation, but also to neuropsychiatric conditions such as delirium and ADHD.
Slowave has identified the United States and Japan as its primary target markets. The USA is experiencing rapid growth in the digital health and neurotechnology sectors, with increasing demand for data-driven assessment of sleep disorders and neuropsychiatric conditions. Building on its research collaboration with the University of Michigan Medical School, the company plans to expand partnerships with major university hospitals and sleep medicine institutions for joint research and clinical application.
Japan, facing rapid population aging, is also seeing increased demand for delirium and sleep disorder management. Slowave plans to secure clinical data through joint research with local university hospitals and research institutions and pursue market entry in collaboration with Japanese medical device companies.
As part of its U.S. expansion strategy, Slowave plans to participate in international exhibitions in 2026 — in order to strengthen its networks with sleep medicine researchers and clinicians, while exploring partnership opportunities with global digital-health companies and investors. Through a phased global partnership strategy, the company aims to expand its presence in the digital neuro-healthcare sector.

 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:

HIFU Dermatology Medical Devices

June 18, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2606E05] BE&BI Tech represents the ultimate combination of Best Electronic Technology and Best Innovation Technology, which reflects its strong belief in pioneering the future through the integration of cutting-edge electronic medical technology and innovative healthcare solutions.
BE&BI Tech specializes in manufacturing High-Intensity Focused Ultrasound (HIFU) devices, focusing on advanced fusion treatment systems, application systems, and skincare and treatment systems.
Through the development of proprietary advanced fusion technologies, BE&BI Tech continuously innovates its products to ensure superior quality and reliability, thereby strengthening its competitiveness in the global market.

High-Intensity Focused Ultrasound System
BE&BI Tech’s UCOS-HIFU effectively removes wrinkles and lifts the skin without direct surgical procedures. As an indirect treatment, it minimizes damage to the skin surface and has no side effects. With a short treatment time of 10 to 30 minutes, it improves skin elasticity and reduces fine wrinkles. What’s more, users can resume daily activities immediately after the procedure.

The UCOS-HIFU system targets specific areas to prevent skin-tissue damage. It is used for wrinkle removal, lifting drooping eyelids, and treating wrinkles around the chin, eyes, and mouth while restoring skin elasticity and regeneration. By regenerating elastin and collagen in the Superficial Muscular Aponeurotic System (SMAS) layer, it naturally improves skin texture and wrinkles. The newly formed tissue within the skin ensures long-lasting results.
“We prioritize customer satisfaction and are fully committed to developing groundbreaking technologies for the betterment of human health. We promise to deliver greater satisfaction through the highest quality and innovative solutions,” remarked the company’s CEO.


 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With: ,

Respiratory Care Equipment

June 18, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2606E04] MEKICS is a company that pioneers a new medical paradigm by expanding the value-chain of respiratory care services, based on its proprietary technology and accumulated achievements.
MEKICS is committed to improving patient-treatment success rates through continuous clinical enhancements and developing innovative products that reflect various medical environments and needs.

Multiple Respiratory Therapy Device
MEKICS’ OmniOx overcomes the limitations of conventional oxygen therapy by providing an innovative solution that adapts flexibly to various patients and conditions with a single device. Designed for use beyond hospitals, it ensures seamless oxygen therapy wherever it is needed, without spatial constraints.
Equipped with a blower, heated humidifier, and built-in oxygen blender, OmniOx is the world’s first device to integrate heated humidified high-flow nasal cannula (HFNC) therapy with CPAP and dual-level non-invasive ventilation (NIV) modes. This enables safe and effective ventilation therapy across diverse environments, from hospitals to home care.

Portable Ventilator
MEKICS’ MV50 is designed to provide essential functions required by clinicians for optimized ventilation, based on various conditions and treatment environments, for both pediatric and adult patients.
It provides flexibility ranging from the intensive care unit to free movement within the hospital, providing the treatment environment desired by clinicians. With MEKICS’ portable ventilator, you can experience the power of personalized solutions and clinically proven methods.
As the global population is aging rapidly, the importance of respiratory-disease management is becoming increasingly critical ― particularly in developed countries where homecare and senior living communities require specialized solutions. In response, MEKICS is developing an integrated service-management system that enables effective respiratory care not only in medical institutions, but also at the individual and community levels.
Beyond being a mere medical-device manufacturer, MEKICS strives to be a trusted partner for both patients and healthcare professionals through relentless research, development, and quality innovation.

“To become a global leader in the field of respiratory therapy, MEKICS will continue to provide next-generation medical solutions incorporating cutting-edge technology, creating value for a healthier and better life,” a spokesperson for the company remarked.
 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With: , ,

Digital Diagnostic X-Ray Systems

June 18, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2606E03] Since its establishment in September 2003, DRGEM Corporation has been dedicated exclusively to the field of X-ray imaging, offering a comprehensive range of solutions for general diagnostic X-ray systems.
Through continuous research, development, and product innovation, DRGEM delivers exceptional X-ray equipment while fulfilling its responsibilities and commitments to its customers, and thereby ensuring their utmost satisfaction.

Auto Positioning System, based on the GXR-SD Digital X-ray System, offers fully automated tracking and positioning for the wall stand and table, thus enhancing workflow efficiency and patient care.
The Auto Positioning System streamlines workflow with fully automated tracking and positioning features, enhancing throughput and improving the experience for both patients and operators by allowing greater focus on patient care.
This motorized system ensures precise and effortless positioning for both the wall stand and table, delivering fast and accurate movements. Integrated with the pre-programmed RADMAX procedure and automated RADMAX image processing, it maximizes efficiency and delivers consistent, high-quality imaging results.

Fully Automated Motor-driven System
Motorized movements across all axes enable fast, accurate positioning with minimal manual input. Predefined positions ensure consistent imaging and streamlined workflow.
A large touchscreen console provides clear visuals and intuitive operation, allowing faster adjustments and improved workflow control.
Ergonomic design and wide-range movement offer easy access to patients and smooth, accurate positioning for various examinations.

Built-in safety sensors prevent collisions by detecting obstacles near the wall Bucky, tube stand, and table. Emergency stop switches at key points allow quick response, ensuring a safe environment for both patients and staff.
The system’s auto rotating touch screen console enhances flexibility and usability by allowing effortless screen rotation, enabling operators to access and control key system functions from various angles, ensuring a seamless workflow.
DRGEM recently completed its successful participation at EXPOSANITA 2026 in Bologna. This premier European event offered a fantastic opportunity to meet leading Italian medical professionals. The company engaged with many global partners to discuss the latest trends in diagnostic imaging at EXPOSANITA 2026. Throughout the event, DRGEM shared its vision for the future of radiology with dedicated industry experts.

Moving Closer to Developing AI-Based Low-Dose C-Arm ‘PROVUE’
DRGEM recently announced that it is driving innovation in the field of fluoroscopy ― technology that uses X-rays to visualize the inside of the human body in real time ― by incorporating artificial intelligence (AI) into image-processing technology for C-arm equipment.

Known as PROVUE, this device analyzes X-ray images acquired at low doses using an AI-based denoising algorithm to remove image noise, thereby significantly reducing radiation exposure for both patients and physicians.
Minimizing X-ray dose during real-time observation of the human body has long been a key technical challenge in fluoroscopy, and achieving high image-quality in a low-dose environment remains a technically difficult task.
A spokesperson for DRGEM explained that the company has achieved tangible results by developing AI-powered image-processing technology through joint research with KAIST.
In particular, this technology has further improved image-noise removal performance by training the AI not only on random noise, but also on real noise data generated in actual clinical environments. DRGEM revealed that through the AI denoising technology applied to PROVUE, it has confirmed the potential to achieve a similar level of image quality at a radiation dose approximately 70% lower than conventional methods.
DRGEM’s CEO explained, “PROVUE is a device developed with a dual focus on enhancing the convenience of medical staff and ensuring the safety of both medical staff and patients,” adding, “We plan to continue developing technology to simultaneously improve the usability and image quality of medical-imaging equipment in the future.”

DRGEM anticipates that technology development will be completed and the product will enter the market in the second half of 2026.
 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With: ,

Laser Medical Devices

June 18, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2606E02] Lameditech Co., Ltd. is a specialized laser medical device company established in 2012. Based on its miniaturized laser technology, Lameditech develops, manufactures, and supplies products that contribute to a healthier and more beautiful life for all.
Its key products include the HandyRay series, which enables peripheral blood sampling without needles, and CAREVEAM, a 308nm excimer laser device for treating skin diseases. Additionally, Lameditech has developed Ray-Vet, a laser-treatment device for pets’ skin ailments.

Blood Sampling Device
Lameditech’s HandyRay series is an innovative blood-sampling device that utilizes lasers to collect peripheral blood without the use of needles. This product overcomes the drawbacks of traditional needle-based lancets by offering advantages such as reduced pain, elimination of secondary infection risks, and prevention of callus formation or needle marks.
Notably, it minimizes discomfort for diabetic patients who require frequent blood glucose monitoring and provides safe and hygienic blood collection for patients of all ages, including newborns. The HandyRay series is available in various models, ranging from personal to hospital and medical institution use, allowing users to choose a suitable model according to their needs.

Home Skincare Device
Lameditech’s PURAXEL is an innovative home-skincare device that brings fractional laser technology from clinics to home use. It combines laser, ultrasound, galvanic, cooling, and LED functions to enhance skin improvement.
Its laser micro-hole technology creates tiny openings in the skin, thereby promoting regeneration and boosting nutrient absorption. This stimulates collagen production, improving elasticity, wrinkles, and skin tone.
Each shot generates about 100 micro-laser holes, thus maximizing absorption while minimizing pain and side effects. Users can enjoy professional skincare at home without the cost, downtime, or discomfort of clinic treatments.

With outstanding technology and reliable quality, Lameditech has gained recognition in both domestic and international markets. The company continues to focus on research and development to lead the global healthcare industry.
“We are also making strides in the beauty-device market with our innovative products, and we remain committed to continuous research and quality improvement for customer satisfaction and to contribute to the growth of the global beauty industry,” remarked a spokesperson for the company.
 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With: , ,

Korean Exporters Breaking their All-Time Monthly Record

June 18, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

Releasing New Competitive Exports Items


 Korea’s exports in May 2026 reached $87.75 billion, breaking the all-time monthly record. Driven by a super-cycle of demand, the semiconductor sector also recorded its highest-ever performance, offsetting the effect of reduced working days due to the holidays.
Monthly exports have exceeded $80 bil. for three consecutive months since first surpassing the $80 bil. mark in March.
Despite the reduced number of working days, exports hit a record high, with the daily average export value rising by 60.7% to $4.28 bil. This marks the first time the figure has surpassed the $4 bil. mark.

Semiconductors were once again the driving force behind exports this month. Semiconductor exports in May reached $37.15 bil., a 169.4% increase from the same month last year, marking an all-time high as they surpassed $30 bil. for the third consecutive month.
Exports of non-semiconductor items also showed a steep upward trend, rising by an average of 16%.
Korean exporters are ceaselessly releasing new products. Towards accomplishing their export performance goals for this year, creative efforts are being made to pioneer their own potential buyers and markets.
MEKICS’ OmniOx overcomes the limitations of conventional oxygen therapy by providing an innovative solution that adapts flexibly to various patients and conditions with a single device. Designed for use beyond hospitals, it ensures seamless oxygen therapy wherever it is needed, without spatial constraints.

BE&BI Tech’s UCOS-HIFU effectively removes wrinkles and lifts the skin without direct surgical procedures. As an indirect treatment, it minimizes damage to the skin surface and has no side effects. With a short treatment time of 10 to 30 minutes, it improves skin elasticity and reduces fine wrinkles. What’s more, users can resume daily activities immediately after the procedure.


 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:

Needle-Free Injector

May 15, 2026 by Leave a Comment
https://korean-electronics.com//inquiry

[INQ. NO. 2605E05] JSKBIOMED Inc. is a biomedical company specializing in laser-based, needle-free injection technology, developing next-generation drug delivery solutions that address the limitations of conventional injection methods ― including pain, infection risk, and medical-waste generation.
Based on proprietary technology that precisely controls the skin barrier using laser energy, the company has established a platform capable of effectively delivering drugs, vaccines, and functional substances, with scalability across medical, aesthetic, and healthcare fields.

Following the stabilization of its core technology in 2025, JSKBIOMED has begun full-scale expansion into overseas markets, entering major countries including Japan, Poland, and Sweden. In Korea, the technology is currently being applied in approximately 300 hospitals and clinics, thereby, demonstrating both technical stability and clinical applicability.
JSKBIOMED recently introduced its laser-based, needle-free injection technology and new product lineup ― aiming to expand strategic partnerships with overseas distributors, medical device companies, and pharmaceutical and biotech firms. The company has been seeking to release collaboration models tailored to country-specific distribution structures and market characteristics while building long-term global networks.
JSKBIOMED’s flagship medical product, MiraJet, utilizes laser-based needle-free injection technology to deliver drugs and active ingredients effectively while minimizing skin damage. It is designed to reduce pain and infection risk while lowering dependency on practitioner skill, thereby enabling a more consistent treatment environment.
JSKBIOMED also recently introduced its aesthetic equipment Jetical Pro 2940, which presents a solution optimized for professional treatment settings. Based on precise laser- control technology, it supports stable energy delivery and enhanced treatment control, and is designed to improve skin condition and increase the efficiency of active ingredient delivery. It can be applied to various skin types and treatment purposes, expanding its usability in professional clinics.

In addition, JSKBIOMED is expanding into the homecare market with the Jetical Mini Pro, a consumer device that integrates the core technology of its medical and professional equipment. Designed with enhanced usability and safety, it enables personalized skincare management, forming an integrated laser-based needle-free injection solution ecosystem across medical, professional, and home-use categories.
JSKBIOMED has identified the United States, Japan, China, France, and Germany as key target markets. These countries represent mature medical and aesthetic device markets with continuously increasing demand for high-performance and high-value aesthetic technologies. The company plans to pursue phased market expansion through collaboration with local buyers, distributors, and global beauty and biotech companies.
In the first half of 2026, JSKBIOMED will be participating in major international exhibitions such as AMWC Monaco and ASLMS in order to strengthen global brand recognition, while promoting its technology and expanding partnerships.
At the same time, JSKBIOMED will pursue country-specific regulatory approvals and certifications in stages and accelerate its growth as a global laser-based needle-free injection platform company through technology licensing, joint development, and diversified collaboration models.

 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods

Filed Under: Cover Story Tagged With:
Next Page»